Avisi Technologies develops a nanotechnology-enabled defense against blindness from glaucoma.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2022 | Seed | $4.06M | 1 | — | — | Detail |
| Sep 1, 2021 | Seed | $1.48M | 1 | — | — | Detail |
| Sep 21, 2020 | Grant | $1M | 1 |
National Science Foundation
|
— | Detail |
| Jun 24, 2019 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |
Gaingels
|
— | Seed |
|
|
— | Seed |